These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8296378)

  • 21. Chloroquine resistance in Plasmodium vivax: the first case in Brazil.
    Garavelli PL; Corti E
    Trans R Soc Trop Med Hyg; 1992; 86(2):128. PubMed ID: 1440766
    [No Abstract]   [Full Text] [Related]  

  • 22. Chloroquine-resistant Plasmodium vivax: it may be a common problem.
    Collignon PJ
    Med J Aust; 1992 Sep; 157(6):426. PubMed ID: 1448003
    [No Abstract]   [Full Text] [Related]  

  • 23. Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.
    Höglund R; Moussavi Y; Ruengweerayut R; Cheomung A; Äbelö A; Na-Bangchang K
    Malar J; 2016 Feb; 15():129. PubMed ID: 26928448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels.
    Baird JK; Leksana B; Masbar S; Fryauff DJ; Sutanihardja MA; Suradi ; Wignall FS; Hoffman SL
    Am J Trop Med Hyg; 1997 Jun; 56(6):621-6. PubMed ID: 9230792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
    Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
    J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine-resistant Plasmodium vivax in Papua New Guinea.
    Schuurkamp GJ; Spicer PE; Kereu RK; Bulungol PK; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1992; 86(2):121-2. PubMed ID: 1440763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat.
    Waheed AA; Ghanchi NK; Rehman KA; Raza A; Mahmood SF; Beg MA
    Malar J; 2015 Apr; 14():146. PubMed ID: 25889875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vivax malaria resistant to chloroquine: case reports from Bombay.
    Garg M; Gopinathan N; Bodhe P; Kshirsagar NA
    Trans R Soc Trop Med Hyg; 1995; 89(6):656-7. PubMed ID: 8594687
    [No Abstract]   [Full Text] [Related]  

  • 29. Chloroquine resistant vivax malaria in an infant: a report from India.
    Zaki SA
    J Vector Borne Dis; 2009 Mar; 46(1):83. PubMed ID: 19326714
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sensitivity of Plasmodium vivax to chloroquine in Laza City, Myanmar].
    Liang GL; Sun XD; Wang J; Zhang ZX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Apr; 27(2):175-6. PubMed ID: 19856512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The specific features of imported Plasmodium vivax malaria, Chesson strain type].
    Rabinovich SA; Kondrashin AV; Tokmalaev AK; Makcakovskaia EV; Sadykova VD; Burchik MA; Begunova SV; Sergiev VP
    Med Parazitol (Mosk); 2012; (4):7-11. PubMed ID: 23437714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America.
    Phillips EJ; Keystone JS; Kain KC
    Clin Infect Dis; 1996 Nov; 23(5):1171-3. PubMed ID: 8922821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The susceptibility of the Indonesian I/CDC strain of Plasmodium vivax to chloroquine.
    Collins WE; Schwartz IK; Skinner JC; Morris C; Filipski VK
    J Parasitol; 1992 Apr; 78(2):344-9. PubMed ID: 1556649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
    Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
    Price RN; Douglas NM; Anstey NM
    Curr Opin Infect Dis; 2009 Oct; 22(5):430-5. PubMed ID: 19571748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of artesunate and chloroquine activities against Plasmodium vivax gametocytes.
    Nacher M; Silachamroon U; Singhasivanon P; Wilairatana P; Phumratanaprapin W; Fontanet A; Looareesuwan S
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2751-2. PubMed ID: 15215143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroquine resistance in Plasmodium--a familiar story.
    Turner JA
    Clin Infect Dis; 1996 Nov; 23(5):1174-5. PubMed ID: 8922822
    [No Abstract]   [Full Text] [Related]  

  • 39. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.
    Rungsihirunrat K; Muhamad P; Chaijaroenkul W; Kuesap J; Na-Bangchang K
    Korean J Parasitol; 2015 Feb; 53(1):43-9. PubMed ID: 25748708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.